Randomized Trial: FLAURA Trial – Treatments for EGFR-Mutated Advanced Non–small-cell Lung Cancer Compared
26 Nov, 2019 | 08:16h | UTCOverall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC – New England Journal of Medicine (free for a limited period)
Commentary: FLAURA Trial: First-Line Osimertinib Improves Overall Survival in EGFR-Mutated Advanced Lung Cancer – The ASCO Post (free)